rhodamine 123 has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capel, P; Delville, JP; Feremans, W; Kiss, R; Pauwels, O; Pradier, O; Van Onderbergen, A | 1 |
Lizard, G; Lizard-Nacol, S; Maynadié, M; Poupon, MF; Roignot, P | 1 |
Amiot, L; Drénou, B; Fauchet, R; Lamy, T; Le Prisé, PY | 1 |
3 other study(ies) available for rhodamine 123 and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Drug Resistance, Multiple; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunohistochemistry; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1995 |
Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Erythroblastic, Acute; Lymphoma, Non-Hodgkin; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines | 1995 |
Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.
Topics: Antigens, CD; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Rhodamine 123; Rhodamines; T-Lymphocytes | 1998 |